Insulinoma presenting as hypoglycemia during lactose tolerance testing: a case report

Journal of Medical Case Reports - Tập 14 Số 1 - 2020
Vicki Munro1, Laura M McDonell2, Valerie Keough3, Ferhan Siddiqi4
1Division of Endocrinology and Metabolism, Department of Medicine, Dalhousie University, Halifax, NS, Canada
2Department of Pathology, Dalhousie University, Halifax, NS, Canada
3Department of Diagnostic Radiology, Dalhousie University, Halifax, NS, Canada
4Queen Elizabeth II Health Sciences Centre, 043-7 North Victoria Building, 1276 South Park Street, Halifax, NS, B3H 2Y9, Canada

Tóm tắt

Abstract Background Insulinoma is a rare functioning pancreatic endocrine tumor, typically presenting as a sporadic solitary lesion causing hypoglycemia. While these tumors can lead to marked autonomic and neuroglycopenic symptoms, the diagnosis is often delayed. Case presentation We present a case of a 60-year-old Caucasian man presenting with a 1-year history of progressive episodic confusion and an unexpected finding of symptomatic hypoglycemia during a lactose tolerance test. Further inquiry revealed an 8-year history of more subtle episodic neuroglycopenic symptoms preceding his presentation. After additional biochemical testing suggested a diagnosis of insulinoma, abdominal imaging was performed and revealed a 1.2-cm tumor in the tail of the pancreas. Following laparoscopic resection of the tumor, the patient had complete resolution of his symptoms and maintained normal glucose levels. Conclusions The clinical presentation of functioning pancreatic neuroendocrine tumors can be subtle and nonspecific. As such, clinicians should remain vigilant for insulinoma when symptomatic hypoglycemia is present. To our knowledge, this is the first report of an insulinoma found after hypoglycemia was detected during lactose tolerance testing.

Từ khóa


Tài liệu tham khảo

Service FJ, McMahon MM, O’Brien PC, Ballard DJ. Functioning insulinoma—incidence, recurrence, and long-term survival of patients: a 60-year study. Mayo Clin Proc. 1991;66(7):711–9.

Melmed S, Williams RH. Williams textbook of endocrinology. Philadelphia: Elsevier/Saunders; 2011.

Harrington MG, McGeorge AP, Ballantyne JP, Beastall G. A prospective survey for insulinomas in a neurology department. Lancet. 1983;1(8333):1094–5.

Valente LG, Antwi K, Nicolas GP, Wild D, Christ E. Clinical presentation of 54 patients with endogenous hyperinsulinaemic hypoglycaemia: a neurological chameleon (observational study). Swiss Med Wkly. 2018;148:w14682.

Eriksson B, Arnberg H, Lindgren PG, Lorelius LE, Magnusson A, Lundqvist G, et al. Neuroendocrine pancreatic tumours: clinical presentation, biochemical and histopathological findings in 84 patients. J Intern Med. 1990;228(2):103–13.

Placzkowski KA, Vella A, Thompson GB, Grant CS, Reading CC, Charboneau JW, et al. Secular trends in the presentation and management of functioning insulinoma at the Mayo Clinic, 1987–2007. J Clin Endocrinol Metab. 2009;94(4):1069–73.

Sugawa T, Murakami T, Yabe D, Kashima R, Tatsumi M, Ooshima S, et al. Hypoglycemia unawareness in insulinoma revealed with flash glucose monitoring systems. Intern Med. 2018;57(23):3407–12.

Tomazic M, Janez A, Ravnik OM. Hypoglycemia identified by a continuous glucose monitoring system in a second-trimester pregnant woman with insulinoma: a case report. J Med Case Rep. 2017;11:117.

Sugiyama Y, Kiuchi C, Suzuki M, Maruyama Y, Wakabayashi R, Ohno Y, et al. Glucose management during insulinoma resection using real-time subcutaneous continuous glucose monitoring. Case Rep Anesthesiol. 2018;2018:6248467.

Tucker ON, Crotty PL, Conlon KC. The management of insulinoma. Br J Surg. 2006;93(3):264–75.

Gouya H, Vignaux O, Augui J, Dousset B, Palazzo L, Louvel A, et al. CT, endoscopic sonography, and a combined protocol for preoperative evaluation of pancreatic insulinomas. AJR Am J Roentgenol. 2003;181(4):987–92.

Okabayashi T, Shima Y, Sumiyoshi T, Kozuki A, Ito S, Ogawa Y, et al. Diagnosis and management of insulinoma. World J Gastroenterol. 2013;19(6):829–37.

Nockel P, Babic B, Millo C, Herscovitch P, Patel D, Nilubol N, et al. Localization of Insulinoma Using 68Ga-DOTATATE PET/CT scan. J Clin Endocrinol Metab. 2017;102(1):195–9.

Hubalewska-Dydejczyk A, Sowa-Staszczak A, Tomaszuk M, Stefanska A. GLP-1 and exendin-4 for imaging endocrine pancreas: a review: labelled glucagon-like peptide-1 analogues: past, present and future. Q J Nucl Med Mol Imaging. 2015;59(2):152–60.

Adler DG, Diehl DL. Missed lesions in endoscopic ultrasound. Endosc Ultrasound. 2015;4(3):165–7.

Belfiori G, Wiese D, Partelli S, Wachter S, Maurer E, Crippa S, et al. Minimally invasive versus open treatment for benign sporadic insulinoma comparison of short-term and long-term outcomes. World J Surg. 2018;42(10):3223–30.

Thông tin
Thông tin xuất bản

Journal of Medical Case Reports

Tập 14 Số 1

Thông tin tác giả